Fierce Pharma Biopharma News Insights Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance
JPM26, Day 1: BMS CEO touts portfolio of blockbuster hopefuls After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco for the industry's big | After a flurry of Big Pharma deals in the
Trump admin rolls out EU trade deal with 15% pharma tariff rate The exact terms of the deal likely provide some relief for the EU’s pharmaceutical industry, which now appears to be immune to higher sectoral tariffs that the Trump administration aims to
Podcasts - Fierce Pharma Podcasts Biopharma and medtech explained Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter
Top 20 pharma companies by 2024 revenue With only one of the biopharma industry’s top 20 revenue companies seeing a year-over-year decline in sales, 2024 was a remarkable year of revenue growth for the industry Compare that to 2023